0YX0 Stock Overview
Engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 0YX0 from our risk checks.
Sysmex Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥18.20 |
| 52 Week High | JP¥18.60 |
| 52 Week Low | JP¥13.00 |
| Beta | 0.64 |
| 11 Month Change | 10.98% |
| 3 Month Change | 9.64% |
| 1 Year Change | 14.71% |
| 33 Year Change | -50.70% |
| 5 Year Change | n/a |
| Change since IPO | -52.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0YX0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 2.2% | -2.5% | -1.3% |
| 1Y | 14.7% | -8.4% | 7.4% |
Return vs Industry: 0YX0 exceeded the German Medical Equipment industry which returned -7.1% over the past year.
Return vs Market: 0YX0 exceeded the German Market which returned 7.1% over the past year.
Price Volatility
| 0YX0 volatility | |
|---|---|
| 0YX0 Average Weekly Movement | 4.6% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 0YX0 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 0YX0's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 10,042 | Kaoru Asano | www.sysmex.co.jp |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Sysmex Corporation Fundamentals Summary
| 0YX0 fundamental statistics | |
|---|---|
| Market cap | €12.06b |
| Earnings (TTM) | €330.06m |
| Revenue (TTM) | €3.03b |
36.5x
P/E Ratio4.0x
P/S RatioIs 0YX0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0YX0 income statement (TTM) | |
|---|---|
| Revenue | JP¥491.29b |
| Cost of Revenue | JP¥228.51b |
| Gross Profit | JP¥262.78b |
| Other Expenses | JP¥209.32b |
| Earnings | JP¥53.46b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 85.73 |
| Gross Margin | 53.49% |
| Net Profit Margin | 10.88% |
| Debt/Equity Ratio | 7.1% |
How did 0YX0 perform over the long term?
See historical performance and comparison